-+ 0.00%
-+ 0.00%
-+ 0.00%

Eterna Therapeutics Changes Name to Ernexa Therapeutics

Benzinga·03/25/2025 12:31:20
Listen to the news

Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the company's new name: Ernexa TherapeuticsSM (NASDAQ:ERNA). The new name reflects the company's laser-focused mission and ambitious vision.

"Eterna Therapeutics began as a pioneer developing an innovative and differentiated cell therapy platform alone, but today, we have entered a new era of evolution and growth," said Sanjeev Luther, President and CEO of Ernexa Therapeutics. "We are an organization with a new strategic focus, one that is advancing transformative cell therapy products with real clinical potential, directly impacting patients' lives and addressing unmet medical needs."